About: Worldwide Clinical Trials (United States)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Worldwide Clinical Trials (United States) Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

company in Morrisville, United States

Attributes	Values
rdf:type	Item
description	bedrijf uit Verenigde Staten van Amerika (nl) company in Morrisville, United States (en)
rdfs:label	Worldwide Clinical Trials (United States) (en)
skos:prefLabel	Worldwide Clinical Trials (United States) (en)
name	Worldwide Clinical Trials (United States) (en)
ROR ID	wds:Q50036835-6C221CF7-4643-436F-8EBB-253094C94352
ROR ID	00cj4je85
instance of	wds:Q50036835-5F5D2992-F1E1-42C5-BFEC-0DFE9EF8C272
instance of	business
country	wds:Q50036835-BAD94B15-9A4A-428C-9F23-7C6E47693F39
country	United States of America
inception	wds:Q50036835-B1C1B975-4C20-4DCA-9077-7BC5F18F9E1E
inception	1986-01-01 00:00:00Z (xsd:dateTime)
headquarters location	wds:Q50036835-5CF3563C-D293-4BB3-8D6E-1AA9991B8747
headquarters location	Morrisville
Crunchbase organization ID	wds:Q50036835-725E04ED-B519-4DC0-8436-3222E8E5B572
ISNI	wds:Q50036835-C798A076-2C8B-4E70-BECD-9A7C52363677
official website	wds:Q50036835-8C4D63D4-55F4-44AF-B248-ADC3DDE5C62F
Crunchbase organization ID	worldwide-clinical-trials
ISNI	000000046052544X
official website	https://www.worldwide.com/
GRID ID	wds:Q50036835-CD7F86C5-0E03-493F-A9E0-B690E7004E12
GRID ID	grid.490299.f
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q50036835
is research site of	Effect of Low-Fat Food on Pexidartinib Pharmacokinetics in Healthy Volunteers Phase 2b Study of KBP-5074 in Subjects With Uncontrolled Hypertension and Advanced Chronic Kidney Disease FX-322 in Sensorineural Hearing Loss A Phase I Study in Healthy Volunteers Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Norketotifen in Healthy Subjects Lofexidine ADME & Mass Balance in Volunteers Safety and Pharmacokinetics of Sustained-release Depot Tacrolimus: A First-in-human Study Lofexidine Food Effect Study in Healthy Volunteers Lofexidine Pharmacokinetics in the Presence of Paroxetine in Healthy Volunteers Study to Evaluate the Safety, Tolerability, and PK of Fulvestrant After IM Administration Evaluating Cerebrospinal Fluid Biomarkers in Alzheimer's, Progressive Supranuclear Palsy Subjects, and Controls OTO-313 in Subjects With Subjective Tinnitus A Study to Compare Bioavailability of Naloxone Nasal Spray, Naloxone Hydrochloride (HCl) Intravenous (IV) and Intramuscular Injection (IM) in Healthy Volunteers Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid A Study of the Effect of Quizartinib on the Pharmacokinetics of the P-gp Substrate Dabigatran Etexilate in Healthy Participants Lofexidine Mass Balance in Volunteers A Phase 1 Study to Evaluate Safety, Tolerability, PK, and PK Interactions of TBA-7371 Study to Assess the Pharmacokinetic Drug-Drug Interactions of Lemborexant When Coadministered With an Oral Contraceptive, Famotidine, or Fluconazole in Healthy Subjects A Study to Compare Bioavailability of Naloxone Nasal Spray and Naloxone Hydrochloride (HCl) Intramuscular Injection (IM) in Healthy Volunteers Crossover Bioequivalence Study of Irbesartan Hydrochlorothiazide 300/25 mg Tablets Under Fed Conditions Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fasted Conditions A Study to Assess Safety, Tolerability, and PK of EDG-5506 in Healthy Volunteers and Becker Muscular Dystrophy Adults Assessment of the Effect of Naltrexone on Lofexidine Single Dose Pharmacokinetics in Healthy Subjects Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fed Conditions Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fed Conditions Effect of Probenecid on Pexidartinib Pharmacokinetics Study to Assess the PK Profile of NanoBUP Capsules Relative to Suboxone Crossover Bioequivalence Study of Irbesartan HCTZ 300/25 mg Tablets Under Fasted Conditions Single Ascending Dose Study of PRX003 in Healthy Subjects Bioequivalence Study to Assess Systemic Exposure of FP and SAL FDC From Different DPIs Randomized, Placebo-controlled, 2 Period, Single-blind, Sequential, Multiple Ascending Dose Study The Effect of CS-3150 Exposure on Corrected QT (QTc) Interval Duration in Healthy Volunteers A Study to Evaluate the Food-Effect of H3B-6527 A Study to Demonstrate Bioequivalence Between Lorcaserin Extended Release (XR) Tablets Manufactured in Kawashima and Lorcaserin XR Tablets Manufactured in Zofingen in Healthy Participants A Study of the Effect of a Moderate CYP3A Inducer Efavirenz on Quizartinib Pharmacokinetics in Healthy Participants
is research site of	wds:Q63573794-01638F21-6C0E-4053-B77C-3502DC8A9ED8 wds:Q64188299-F2699790-BA76-45EA-A232-6E4EE44A0CBB wds:Q61904860-4121B2BB-3F10-409E-9B1A-7EF3130F9799 wds:Q63592470-761F3A52-FF1C-444C-B0A7-611CC3B1BA33 wds:Q63599085-ABD2215D-196E-45E4-A475-02CCAA831CB2 wds:Q63339344-FB6E312C-F251-4580-97F6-4A6BD98CCFB7 wds:Q63393631-E3E804BD-EAA5-4334-B22D-43BBB3F6E825 wds:Q64647831-3F1320B0-431E-4E21-993D-E2069E825D7A wds:Q65399493-1E9760FD-008D-4E01-A7D3-D8C6267F8C3A wds:Q63534576-E93639F5-235E-44F1-B815-151871854FCD wds:Q63335580-19E2ECAE-97B0-4C19-8B22-887C75328B02 wds:Q64183555-523A02BC-7CA7-4177-A288-3D0045E9B506 wds:Q64793218-913CA94A-B2C1-4A50-B8D4-C272EDF1226B wds:Q66042503-D9B716B7-9224-4C5C-8BB5-F799767EBAF6 wds:Q99529963-A04A4D84-46DF-4517-AAE5-A3CAAE8C3F15 wds:Q64643794-D331AA44-0015-43E6-872C-7569374DFD95 wds:Q66042500-DA46D2BA-3B83-450D-9711-6C7169D94066 wds:Q63400816-40217547-4DA0-4E63-8224-B96FD808DF51 wds:Q64793220-54EB7502-415C-4773-976D-F853719B5E25 wds:Q64638758-602DC3F3-407D-44D5-828F-3B8B519741C1 wds:Q64638761-46192275-AC67-4571-B3A6-76C424DDD2AB wds:Q102153445-A5592E0A-A005-4E7E-BEF3-0D27F310B69F wds:Q64396020-5E873FFC-3433-464E-AB59-25B88C89AFD6 wds:Q64638763-2F4DA4EA-D88E-468C-85E5-06BFB22F58C3 wds:Q64640035-0B433531-0FAA-4954-8369-79752D080920 wds:Q66070978-F01FED21-3EFA-46C8-902C-544D0DB4ECD8 wds:Q63817467-E9F087AF-8928-4ACD-9C18-37E7257AF064 wds:Q64638756-52D01FC3-1AB4-4393-8CC6-03C9262C9A51 wds:Q65347268-B3AFC280-2FA3-4431-9207-301AFCD78173 wds:Q65352216-50FDE5D5-FF94-4DD6-8329-8E1025D47A79 wds:Q64353625-8B92A5D1-0478-41CB-9627-D5D52BDC0EC9 wds:Q66061609-C55A7675-37BC-4D6F-90B1-233BB193FBEE wds:Q63402093-8FBA3E83-BAEE-48D9-B48A-4A49DA1F773B wds:Q63393422-EDB966F1-93E3-4398-BD8C-8593211A8C3E wds:Q99529962-B0AACC68-4A24-4E64-94EF-B42C7EBDFA3A
is contributor to the...e work or subject of	Phase 2b Study of KBP-5074 in Subjects With Uncontrolled Hypertension and Advanced Chronic Kidney Disease Observational Study to Evaluate Vandetanib in RET -/+ Patients With Metastatic Medullary Thyroid Cancer Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia With Lewy Bodies Evaluate NYX-458 in Subjects With MCI-PD A Study of Bryostatin in Moderately Severe to Severe Alzheimer's Disease Subjects Not On Memantine

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software